Drug Trial Radar · NCT02187055
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
Last checked: Nov 20, 2026Latest source record: Jun 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,152
Actual
Start
Aug 2014
Primary completion
Dec 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jul 10, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the efficacy of tofacitinib monotherapy or tofacitinib with methotrexate as compared to adalimumab with methotrexate. To compare the efficacy of tofacitinib monotherapy compared to tofacitinib combined with methotrexate. To compare effects on all health outcomes measures in the study. To evaluate the safety and tolerability of tofacitinib and adalimumab. To evaluate the safety of the zoster vaccine given prior to the initiation of tofacitinb or adalimumab.
Conditions
- Rhematoid Arthritis
Interventions
Tofacitinib with methotrexateDrug
Tofacitinib 5 mg twice daily, oral for 12 months Methotrexate (previous stable dose 15-25 mg) every week, oral for 12 months Placebo for adalimumab every other week, subcutaneous for 12 months
Tofacitinib without methotrexateDrug
Tofacitinib 5 mg twice daily, oral for 12 months Placebo for methotrexate (previous stable dose) every week, oral for 12 months Placebo for adalimumab every other week, subcutaneous for 12 months
Adalimumab with methotrexateBiological
Placebo for tofacitinib twice daily, oral for 12 months Methotrexate (previous stable dose 15-25 mg) every week, oral for 12 months Adalimumab 40 mg every other week, subcutaneous for 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving American College of Rheumatology Criteria 50% Improvement (ACR50) Response at Month 6Time frame: Month 6
Locations
215 sites in 25 countries. Site status is shown where the registry gives one.
Rheumatology Associates of North Alabama, PC
Huntsville, Alabama
Arthrocare, Arthritis Care & Research, PC
Gilbert, Arizona
Medvin Clinical Research
Covina, California
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare
Fullerton, California
HealthCare Partners Medical Group
Huntington Beach, California
Keck Medicine of USC - Division of Rheumatology
Los Angeles, California
University of Southern California (USC) Norris Comprehensive Cancer Center
Los Angeles, California
Ronald Reagan UCLA Medical Center - Drug Information Center
Los Angeles, California
UCLA David Geffen School of Medicine, Division of Rheumatology
Los Angeles, California
Medvin Clinical Research
Placentia, California
San Diego Arthritis Medical Clinic
San Diego, California
Inland Rheumatology Clinical Trials, Inc.
Upland, California
Medvin Clinical Research
Van Nuys, California
Medvin Clinical Research
Whittier, California
Joao M. A. Nascimento
Bridgeport, Connecticut
AARDS Research, Inc.
Aventura, Florida
Arthritis and Rheumatic Disease Specialties
Aventura, Florida
Riverside Clinical Research
Edgewater, Florida
Centre for Rheumatology, Immunology and Arthritis
Fort Lauderdale, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Omega Research Consultants, LLC
Orlando, Florida
Arthritis Center, Inc.
Palm Harbor, Florida
Gulf Region Clinical Research Institute Llc
Pensacola, Florida
West Broward Rheumatology Associates, Inc.
Tamarac, Florida
BayCare Medical Group Inc
Tampa, Florida
The Center for Arthritis and Rheumatism
Vero Beach, Florida
The Office of Alastair C. Kennedy, MD
Vero Beach, Florida
Advanced Clinical Research of Orlando, Inc.
Winter Garden, Florida
Coeur D'Alene Arthritis Clinic
Coeur d'Alene, Idaho
Institute of Arthritis Research
Idaho Falls, Idaho
Deerbrook Medical Associates
Vernon Hills, Illinois
Diagnostic Rheumatology and Research PC
Indianapolis, Indiana
Ochsner Clinic Baton Rouge
Baton Rouge, Louisiana
Arthritis and Diabetes Clinic, Inc
Monroe, Louisiana
Arthritis Treatment Center
Frederick, Maryland
Jasper Clinic
Kalamazoo, Michigan
Arthritis and Osteoporosis Treatment and Research Center
Flowood, Mississippi
Clinvest/ A Division of Banyan Group, Inc.
Springfield, Missouri
St. Louis Center For Clinical Research Barbara Caciolo, MD
St Louis, Missouri
Dr. Prem C. Chatpar M.D.,LLC
Plainview, New York
Showing 40 of 215 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.